TP53 and neoplasm: The above results are in line with recent studies [30,31], suggesting that mutations in the p53 protein-coding region in pancreatic cancer cells promote an antiapoptotic phenotype in CAFs, capable of establishing a tumor-supportive and pro-metastatic environment.